Skip to main content
Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
97.10
+1.16 (1.21%)
At close: Mar 9, 2026, 4:00 PM EDT
95.16
-1.94 (-2.00%)
After-hours: Mar 9, 2026, 6:15 PM EDT

Incyte Revenue

In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth. Incyte had revenue of $1.51B in the quarter ending December 31, 2025, with 27.84% growth.

Revenue (ttm)
$5.14B
Revenue Growth
+21.22%
P/S Ratio
3.76
Revenue / Employee
$1,807,750
Employees
2,844
Market Cap
19.32B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.14B900.03M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genmab 3.72B
BioNTech SE 3.70B
BioMarin Pharmaceutical 3.22B
Royalty Pharma 2.38B
Moderna 1.94B
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
Insmed 606.42M
Revenue Rankings

INCY News

More News